Magnetoencephalographic parietal δ dipole density in mild cognitive impairment: Preliminary results of a method to estimate the risk of developing Alzheimer disease

Archives of Neurology

Volumn 63, Issue 3, 2006, Pages 427-430

  Fernández, Alberto ^a   Turrero, Agustín ^a   Zuluaga, Pilar ^a   Gil, Pedro ^b   Maestú, Fernando ^a   Campo, Pablo ^a   Ortiz, Tomás ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENSITY; DIPOLE; DISEASE CLASSIFICATION; FOLLOW UP; HEALTH STATUS; HUMAN; MAGNETOENCEPHALOGRAPHY; MILD COGNITIVE IMPAIRMENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; WAVEFORM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MAGNETOENCEPHALOGRAPHY; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; RISK;

EID: 33644902951     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.3.427     Document Type: Article

References (22)

1. Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000;343:450-456.
2. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194.
3. Shah Y, Tangalos EG, Petersen RC. Mild cognitive impairment: when is it a precursor to Alzheimer's disease? Geriatrics. 2000;55:62, 65-68.
4. Prichep LS, John ER, Ferris SH, et al. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging. 1994;15:85-90.
5. Jelic V, Johansson SE, Almkvist O, et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging. 2000;21:533-540.
6. Huang C, Wahlund L, Dierks T, et al. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol. 2000;111:1961-1967.
7. Fernandez A, Maestu F, Amo C, et al. Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Biol Psychiatry. 2002;52:764-770.
8. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
9. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
10. Lobo A, Ezquerra J, Gomez Burgada F, Sala JM, Seva Diaz A. Cognocitive minitest (a simple practical test to detect intellectual changes in medical patients) [in Spanish]. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1979;7:189-202.
11. Auer S, Reisberg B. The GDS/FAST staging system. Int Psychogeriatr. 1997;9(suppl 1):167-171.
12. Oppenhein A, Schafer R. Digital Signal Processing. Englewood Cliffs, NJ: Prentice-Hall International Inc; 1974.
13. Fernandez A, Arrazola J, Maestu F, et al. Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. AJNR Am J Neuroradiol. 2003;24:481-487.
14. Fernandez A, García-Segura J, Ortiz T, et al. Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease. Dement Geriatr Cogn Disord. 2005;20:169-177.
15. Fernandez A, de Sola RG, Amo C, et al. Dipole density of low-frequency and spike magnetic activity: a reliable procedure in presurgical evaluation of temporal lobe epilepsy. J Clin Neurophysiol. 2004;21:254-266.
16. Fernandez A, Rodriguez-Palancas A, Lopez-Ibor M, et al. Increased occipital delta dipole density in major depressive disorder determined by magnetoencephalography. J Psychiatry Neurosci. 2005;30:17-23.
17. Fehr T, Kissler J, Moratti S, et al. Source distribution of neuromagnetic slow waves and MEG-delta activity in schizophrenic patients. Biol Psychiatry. 2001;50:108-116.
18. Hirono N, Kitagaki H, Kazui H, et al. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke. 2000;31:2182-2188.
19. Bozzali M, Cercignani M, Sormani MP, et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol. 2002;23:985-988.
20. Kikuchi M, Wada Y, Koshino Y, et al. Effects of scopolamine on interhemispheric EEG coherence in healthy subjects: analysis during rest and photic stimulation. Clin Electroencephalogr. 2000;31:109-115.
21. Osipova D, Ahveninen J, Kaakkola S, et al. Effects of scopolamine on MEG spectral power and coherence in elderly subjects. Clin Neurophysiol. 2003;114:1902-1907.
22. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405.